BioPharma Credit PLC
BOPCF
$0.96
$0.011.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.31% | 9.27% | 12.58% | 12.62% | 12.66% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19,179.35% | -199.64% | -139.34% | -121.36% | -99.62% |
| Change in Net Operating Assets | -105.05% | -323.18% | -752.71% | -237.99% | -12.34% |
| Cash from Operations | -18.60% | -25.05% | -30.19% | -20.36% | -9.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.31% | 88.73% | 79.14% | 191.49% | 2,459.42% |
| Cash from Investing | 98.31% | 88.73% | 79.14% | 191.49% | 2,459.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 51.52% | 28.94% | -1.11% | -92.52% | -514.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 26.66% | 39.18% | 51.00% | 10.23% | -58.11% |
| Other Financing Activities | 53.66% | -16.72% | -320.76% | -259.76% | -215.24% |
| Cash from Financing | 42.35% | 26.11% | 4.44% | -51.73% | -162.09% |
| Foreign Exchange rate Adjustments | 1,950.00% | 766.67% | 428.57% | 250.00% | 71.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.38% | 83.85% | -6.85% | -901.25% | -991.04% |